Eclitasertib (DNL-758) is a potent receptor-interacting protein kinase 1 (RIPK1) inhibitor with an IC50 of <1 µμ (From patent WO2017136727A2, example 42)[1].
[1]. Anthony A. ESTRADA, et al. Compounds, compositions and methods. WO2017136727A2.
Eclitasertib (DNL-758) is a potent receptor-interacting protein kinase 1 (RIPK1) inhibitor with an IC50 of <1 µμ (From patent WO2017136727A2, example 42)[1].
[1]. Anthony A. ESTRADA, et al. Compounds, compositions and methods. WO2017136727A2.